Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: a retrospective observational study

Abstract

Based on the present results from a large clinical cohort, TTG may be used as a new early to intermediate end-point to describe the ALS natural history. TTG may be potentially useful as a new primary outcome measure for clinical trials.